Loading resource…

Department of Medicine, University of Melbourne; Department of Endocrinology, The Austin Hospital; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel; Department of Clinical Research, University of Basel
Hyponatremia is the most common electrolyte disorder encountered in hospitalized patients, with SIAD being a leading cause of severe cases. The document discusses the clinical presentation of SIAD, the importance of careful sodium correction to avoid complications such as osmotic demyelination syndrome, and outlines current treatment guidelines. It emphasizes fluid restriction as the first-line therapy and explores second-line options, including tolvaptan and other agents, while addressing the risks associated with their use.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology

2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology

METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology

GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology

DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology

ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology

DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology

OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology

ROLE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN ACHIEVING WEIGHT LOSS AND IMPROVING CARDIOVASCULAR OUTCOMES IN PEOPLE WITH OVERWEIGHT AND OBESITY
Same clinical topic · Endocrinology